The mechanisms responsible for reduced arterial distensibility in renal transplant recipients remain to be evaluated. The present longitudinal study was aimed to evaluate the effect of hypertension on the evolution of vessel wall properties in renal transplant recipients. The mechanical properties of the common carotid artery were determined in 24 normotensive and 24 treated hypertensive renal transplant recipients 6-12 weeks after transplantation. The measurements were repeated after 2 years. Arterial distension was determined by using a multigate pulsed Doppler system, blood pressure (BP) was measured by a mercury sphygmomanometer. BP was 127 ؎ 3/80 ؎ 2 mm Hg at entry and 133 ؎ 3/82 ؎ 2 mm Hg after 2 years in the normotensive group, 146 ؎ 4/90 ؎ 3 mm Hg at entry and 145 ؎ 3/87 ؎ 2 mm Hg after 2 years in the hypertensive group (P Ͻ 0.01, normotensives vs hypertensives). The distens-
Introduction
Structural changes of the arterial wall affect the mechanical properties of the arterial system. 1, 2 The resultant impairment in buffering capacity on pulsatile pressure and the increased amplification of pressure wave reflected from the periphery can increase systolic pressure and left ventricular load and is associated with a higher cardiovascular risk. [1] [2] [3] [4] Structural and mechanical properties of the arterial wall are altered in patients with renal failure. [5] [6] [7] [8] It has been shown that the distensibility of large arteries is reduced in haemodialysis patients and in renal transplant recipients. [6] [7] [8] Moreover it had been demonstrated that intima-media-thickness is increased in end-stage renal failure and is related to the mechanical properties of the arterial wall. 6 The mechanisms responsible for the arterial stiffness in patients with end-stage renal failure remain to be evaluated. Age is known to affect the vessel wall properties 9, 10 and the aging processes of the arterial wall appear to be accelerated in patients with end- ؊3 /kPa after 2 years, NS). There was a significant correlation between the change of the distensibility coefficient after 2 years and mean arterial pressure (n ‫؍‬ 48, r ‫؍‬ 0.42, P Ͻ 0.01). The results show that the decrease of arterial distensibility after 2 years is accelerated in hypertensive renal transplant recipients despite effective anti-hypertensive treatment. Since BP levels were not different at entry into the study and after 2 years, differences in distending pressure along cannot explain the more pronounced decrease of arterial distensibility over time in hypertensive renal transplant recipients.
stage renal failure. 8 Several cross-sectional studies have shown that the distensibility and compliance of large arteries are reduced in hypertensive patients with normal kidney function. 2, 11 Two different mechanisms have been suggested to explain the change of vessel wall properties: structural modifications due to adaptive or degenerative changes of the vessel wall or functional factors due to differences in distending pressure. 11 Up to now, there are no longitudinal studies investigating the effects of high blood pressure (BP) on the mechanical vessel wall properties of large arteries. In renal transplant recipients high BP is very common 12 and may play an important role for the vessel wall properties. In order to investigate the influence of hypertension on the evolution of the mechanical vessel wall properties in renal transplant recipients, we compared vessel wall properties in normotensive and hypertensive patients during a 24-months' observation period.
Patients and methods
Vessel wall properties were determined in renal transplant recipients 6-12 weeks after transplantation. The measurements were repeated after 2 years. The renal transplant recipients were eligible for the study if the transplant function was stable and serum creatinine level was below 3 mg/dl. The following exclusion criteria were used: renal artery stenosis, myocardial infarction within 6 months prior to the start of the study, cerebrovascular disease, diabetes (type I and II) and more than two renal transplantations. Control visits were scheduled monthly during the observation period in all patients for BP measurement and clinical examination. BP was determined by sphygmomanometry using the arm without arteriovenous fistula after a 10-min rest in a sitting position. The patients were divided into two groups. Normotensive patients had a diastolic BP (DBP) Ͻ90 mm Hg measured at a minimum of two different days in the 4 weeks preceding entrance into the study and were not on antihypertensive drugs. Hypertensive patients had a DBP Ͼ90 mm Hg measured at a minimum of two different days in the 4 weeks prior to enrolment into the study. At enrolment, nine patients were treated with an anti-hypertensive monotherapy, six patients were on two anti-hypertensive drugs and seven hypertensives on three anti-hypertensive drugs. In two cases a combination of four anti-hypertensive drugs was given (calcium-antagonist n = 12, diuretic n = 17, beta-blocker n = 11, ACE-inhibitor n = 7, alpha-blocker n = 3). If DBP increased above 90 mm Hg during the study, anti-hypertensive therapy was increased. On average 2.1 ± 0.2 anti-hypertensive drugs were given at enrolment and 2.3 ± 0.3 after 2 years. The number of anti-hypertensive drugs changed in 10 patients during the observation period (increased in seven patients, decreased in three patients). Long-term immunosuppression consisted of either cyclosporine and prednisolone (5-10 mg/day) or cyclosporine, prednisolone and azathioprine (1.5-2 mg/day/kg body weight). Cyclosporine trough blood levels were individually adjusted to 100-150 ng/ml (HPLC method).
A total of 36 hypertensive and 33 normotensive renal transplant recipients were enrolled into the study. During the period of 2 years, three hypertensive and two normotensive patients dropped out because of renal transplant failure. Three hypertensive and two normotensive patients were lost to follow-up. Since differences in distending pressure affect arterial distensibility, a further 11 patients with significant BP changes after entry into the study were excluded. Five normotensive patients developed hypertension, two hypertensive patients became normotensive after enrolment. In four hypertensive patients DBP differed by more than 10 mm Hg after 2 years, when compared with BP level at enrolment.
The vessel wall properties were studied in the morning before immunosuppressive and anti-hypertensive drugs were taken. After supine rest of 10 min, the left common carotid artery was studied 2 cm below the bifurcation using a multi-gate pulsed Doppler system. 13, 14 The method is based upon the processing of low frequency Doppler signals originating from the sample volumes coinciding with the anterior and posterior vessel walls. The positions of the sample volumes are continuously adjusted according to the displacement of the wall.
The Doppler signals in M-mode are temporarily stored and analysed by a personal computer. The resolution for a 6.1-Mhz Doppler system is equivalent to a displacement of 31.25 m (assuming a speed of sound of 1525 m/s), which far exceeds the resolution capacity of a real-time scanner for static objects. Since both the recorded changes in diameter and the initial diameter similarly depend on the angle of observation, the ratio of both will be angle independent. The system allows the assessment of the relative change of major peripheral arteries as a continuous function of time with an accuracy of about 0.5%. BP was determined on the brachial artery using a mercury sphygmomanometer before the vessel wall movements were determined. The shunt arm was never used for this measurement. Using this non-invasive technique, the end-diastolic diameter (d [mm] ) and the systolic increase of vessel diameter (Dd [m]) were measured. From these data and from the systolic and diastolic BP (SBP, DBP), the relative systolic increase of vessel diameter (Dd
) and the arterial wall distensibility coef-
]) were calculated. 14 Values are given as mean ± standard error of the mean (s.e.m.). The clinical and biochemical parameters between normotensive and hypertensive renal transplant recipients and/or between at entry into study and after 2 years were tested for statistical significance by the Student's t-test or by an analysis of variance. Regression analysis was also performed to analyse the correlation between the change of the distensibility coefficient after 2 years and mean arterial pressure. Values of P Ͻ0.05 were considered to be statistically significant.
Results
Age, gender and body mass index were not statistically different between the normotensive and hypertensive group of renal transplant recipients ( Table  1 ). The duration of haemodialysis prior to transplantation was insignificantly longer in the normotensive than in the hypertensive group (Table 1) . Serum creatinine at enrolment was significantly lower in the normotensive group when compared with the hypertensive group (Table 2 ). In the normotensive and hypertensive group serum creatinine increased after 2 years although the rise of serum creatinine was only statistically significant in the hypertensive group (Table 2) . Cyclosporine trough blood levels, haemoglobin and cholesterol did not significantly differ in the normotensive and hypertensive group at enrolment and after 2 years. In both groups haemoglobin increased significantly after 2 years (Table 2) . At the time of enrolment hypertension was already treated in the hypertensive renal transplant recipients resulting in a mean BP below 150/95 mm Hg. However, systolic and diastolic BP levels of the hypertensive renal transplant recipients were significantly different at time of enrolment and after 2 years when compared with the normotensive group (Table 3) . No significant change of systolic and diastolic BP was observed either in the normotensive or in the hypertensive group after 2 years when compared with baseline levels (Table 3) .
Systolic and diastolic BP determined at the At enrolment, end-diastolic diameter of the carotid artery was considerably lower in normotensive than in hypertensive patients. There were little differences between the two groups in the absolute and relative diameter change and distensibility coefficient of the common carotid artery (Table 3 ). In the normotensive group, vessel wall parameters of the common carotid artery did not change significantly after a period of 2 years (Table 3 ). In the hypertensive renal transplant group, end-diastolic vessel diameter of the common carotid artery was not different after 2 years. In contrast to the normotensive group, the other vessel wall parameters of the common carotid artery changed significantly after 2 years in the hypertensive group (Table 3) . Thus, the absolute and relative distension decreased significantly after 2 years. A significant reduction after 2 years was also observed for the distensibility coefficient in the hypertensive renal transplant recipients.
Mean arterial pressure averaged over the 2 years observation period was related to the change in arterial distensibility after 2 years. There was a significant correlation between the change of the distensibility coefficient after 2 years and mean arterial BP when normotensive and hypertensive patients were pooled together (n = 48, r = 0.42, P Ͻ 0.01, Figure 3) . A significant correlation between the change of the distensibility coefficient after 2 years and mean arterial BP was also observed in the hypertensive group (n = 24; r = 0.47, P Ͻ 0.05) but not in the normotensive group (n = 24; r = 0.14, NS).
Discussion
In recent years, attention has been directed to the structural and functional properties of large arteries. Several studies have shown that modifications of the vessel wall properties are common in haemodialysis patients and after renal transplantation. [5] [6] [7] [8] . In renal transplant recipients, arterial distensibility of large arteries is reduced and the impaired arterial buffering capacity seems to contribute to cardiovascular morbidity after renal transplantation. 4 There are no studies evaluating the mechanisms responsible for altered vessel wall properties in patients with renal failure. The present longitudinal investigation was aimed to evaluate the effects of hypertension on the mechanical vessel wall properties in renal transplant recipients. The results indicate that the decrease of arterial distensibility over time is more pronounced in hypertensive renal transplant recipients despite anti-hypertensive therapy. Since BP levels were not different at entry into the study and after 2 years, differences in distending pressure cannot explain the more pronounced decrease of arterial distensibility in hypertensive renal transplant recipients.
Several studies have shown that the distensibility and compliance of large arteries are decreased in essential hypertension and in systolic hypertension Figure 3 Correlation between the change of distensibility coefficient after 2 years and mean arterial BP averaged over the 2-year observation period in the group of normotensive and hypertensive renal transplant recipients (n = 48, r = 0.42, P Ͻ 0.01).
when compared with normotensive controls. 2, 11, [15] [16] [17] Comparisons of mechanical vessel wall properties in normotensive and hypertensive patients are hampered, since the pressure-volume relationship in large arteries its not linear and the mechanical vessel wall properties can only be defined in terms of a given pressure. 11 Decreased arterial distensibility in hypertension can be the result of increased levels of distending pressure or may reflect chronic structural changes. Earlier observations in essential hypertension have inferred the existence of structural changes of the arterial wall rather than differences in distending pressure. 2, 11 Recent studies indicate that differences in distending pressure account for arterial stiffness in essential hypertension. 18, 19 Laurent et al 19 have shown that the decrease in arterial distensibility was primarily due to higher distending BP rather than to structural modifications, and when adjusted for differences in BP, hypertrophied arteries of essential hypertensive subjects were more distensible than those of normotensive controls. In contrast to the results in essential hypertensive subjects, arterial stiffness in hypertensive patients with end-stage renal failure appear to be related to structural vessel wall changes. 6, 20 London et al 6 have shown that reduced arterial distensibility in haemodialysis patients is associated with an increase of intima-media-thickness. The results of the present study can also not be explained by differences in distending pressure, since both normotensive and hypertensive renal transplant recipients had nearly constant BP levels throughout the observation period.
Arterial distensibility changes with increasing age due to degenerative processes of the vessel wall. 9, 10 End-stage renal failure appears to accelerate the alterations of mechanical vessel wall properties induced by aging. Intrinsic structural changes of the arterial wall and vascular smooth muscle activity or a combination of both factors are reported to be the most important determinants of mechanical vessel wall properties of the large arteries. 21, 22 Hypertrophy of connective tissue with an increased collagen-toelastin ratio are characteristic arterial wall changes in aging leading to impaired arterial distensibility. 9, 22 In uremic patients the collagen-to-elastin ratio of the arterial wall is increased 23 suggesting that pre-existing irreversible changes of the arterial wall are also common in patients shortly after renal transplantation. Nevertheless, hypertension exerted further adverse effects on arterial distensibility in renal transplant recipients despite pre-existing irreversible structural vessel wall modifications. A chronic increase in tensile stress, such as that which occurs during hypertension, may contribute to hypertrophy of connective tissue. The decrease in elastin and the increase in collagen has been attributed to the fatiguing effects of cyclic stress. 24 Cyclic stress acts on the inert non-living elastic fibres, resulting in their fracture and separation, with subsequent stretching of the arterial wall. Increased cyclic stress may be related to the increased arterial diameter, which we observed in the group of hypertensive renal transplant recipients. However, changes of the vascular smooth muscle may also play an important role for the findings of the present study. It has been shown that a chronic increase in tensile stress can induce an increase of wall thickness associated with a hypertrophy of vascular smooth muscle. 20 On the other hand, high BP in renal transplant recipients was sufficiently treated by anti-hypertensive drugs and some renal transplant recipients were treated with calcium-antagonists or ACE-inhibitors which are known to improve arterial distensibility. 11, 24 Since the effects of increased tensile stress appear to be attenuated by anti-hypertensive therapy, other factors associated with post-transplant hypertension may explain our results. The response of vascular smooth muscle to vasoconstrictor stimuli is increased in hypertension. 25, 26 Vasoconstrictor stimuli can affect vessel wall properties. Noradrenaline and angiotensin can decrease arterial compliance in response to an infusion before there is a prominent increase of vascular resistance. 27 Cyclosporine may enhance the influence of hypertension on the mechanical vessel wall properties. Vasoconstriction and the response to vasoconstrictor stimuli can be increased in cyclosporine immunosuppression. 28 Vessel wall properties may be affected by sympathetic overactivity which can be observed in cyclosporine treated patients. 29 Moreover, the effects of cyclosporine on the vessel wall function may also be related to structural modifications. Cyclosporine can increase thromboxane excretion. 30 Thromboxane has been shown to cause smooth muscle contraction as well as proliferation of smooth muscle cells. 31 In conclusion, the present longitudinal study suggests that the decrease of arterial distensibility over time is more pronounced in hypertensive renal transplant recipients despite effective anti-hypertensive therapy. Differences in distending pressure alone cannot account for the lower arterial distensibility after 2 years since BP levels did not change significantly in both normotensive and hypertensive renal transplant recipients. The effect of hypertension on mechanical vessel wall properties in renal transplant recipients are therefore likely to be related to intrinsic vessel wall changes.
